Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Gland Pharma Ltd. ( (IN:GLAND) ) is now available.
Gland Pharma Limited has announced the receipt of a Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending March 31, 2025. This certificate, issued by MUFG Intime India Private Limited, confirms the dematerialization status of securities and their listing on stock exchanges, ensuring compliance with regulatory requirements and maintaining transparency for stakeholders.
More about Gland Pharma Ltd.
Gland Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of complex injectables. The company is known for its extensive portfolio of generic injectables and its emphasis on quality and compliance in its operations.
YTD Price Performance: -21.23%
Average Trading Volume: 11,256
Current Market Cap: 233.1B INR
For detailed information about GLAND stock, go to TipRanks’ Stock Analysis page.